Page last updated: 2024-09-04

13,14-dihydroprostaglandin e1 and alprostadil

13,14-dihydroprostaglandin e1 has been researched along with alprostadil in 23 studies

Compound Research Comparison

Studies
(13,14-dihydroprostaglandin e1)
Trials
(13,14-dihydroprostaglandin e1)
Recent Studies (post-2010)
(13,14-dihydroprostaglandin e1)
Studies
(alprostadil)
Trials
(alprostadil)
Recent Studies (post-2010) (alprostadil)
27237,136864761

Protein Interaction Comparison

ProteinTaxonomy13,14-dihydroprostaglandin e1 (IC50)alprostadil (IC50)
Multidrug resistance-associated protein 4Homo sapiens (human)2.3
Solute carrier organic anion transporter family member 2B1Rattus norvegicus (Norway rat)0.0358

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's22 (95.65)18.2507
2000's1 (4.35)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, TL; Sharif, NA1
Gerakakis, A; Keiler, A; Lupattelli, G; Peskar, BA; Sinzinger, H; Virgolini, I1
Leonhardt, A; Schweer, H; Seyberth, HW; Wolf, D1
Firbas, W; Neumann, I; Rogatti, W; Sinzinger, H; Virgolini, I1
Braun, M; Bruch, L; Ney, P; Schrör, K; Szymanski, C1
Hesse, WH; Peskar, BA; Rudofsky, G1
Braun, M; Bruch, L; Hohlfeld, T; Ney, P; Schrör, K; Szymanski, C1
Fitscha, P; O'Grady, J; Peskar, BA; Rauscha, F; Rogatti, W; Sinzinger, H1
Diehm, C; Hesse, WH; Peskar, BA; Rogatti, W; Rudofsky, G; Schweer, H; Seyberth, HW1
Fitscha, P; Gerakakis, A; Li, SR; O'Grady, J; Sinzinger, H; Virgolini, I1
Cawello, W; Schweer, H; Seyberth, HW1
Akarasereenont, P; Hide, E; Ney, P; Thiemermann, C; Vane, JR1
Baumann, G; Bruch, L; Kästner, A; Modersohn, D; Ney, P1
Bonn, R; Cawello, W; Müller, R; Schweer, H; Seyberth, HW1
Meese, CO; Schweer, H; Seyberth, HW; Watzer, B1
Pallapies, D; Peskar, BA2
Kritz, H; O'Grady, J; Peskar, BA; Rodrigues, M; Rogatti, W; Sinzinger, H1
Hide, EJ; Ney, P; Piper, J; Thiemermann, C; Vane, JR1
Bräutigam, M; Misselwitz, B1
Albrecht, D; Cawello, W; Dietrich, B; Fox, A; Hohmuth, H; Schweer, H; Seyberth, HW1
Gallant, C; Goldstein, I; Huang, YH; Moreland, RB; Traish, AM1
Neumann, I; O'Grady, J; Peskar, BA; Rogatti, W; Sinzinger, H1

Reviews

1 review(s) available for 13,14-dihydroprostaglandin e1 and alprostadil

ArticleYear
13,14-Dihydro-prostaglandin E1 in atherosclerosis.
    Seminars in thrombosis and hemostasis, 1993, Volume: 19, Issue:2

    Topics: Alprostadil; Animals; Arteriosclerosis; Humans; Male; Platelet Aggregation; Rats; Rats, Wistar

1993

Trials

2 trial(s) available for 13,14-dihydroprostaglandin e1 and alprostadil

ArticleYear
Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects.
    European journal of clinical pharmacology, 1994, Volume: 46, Issue:3

    Topics: Adult; Alprostadil; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Infusions, Intravenous; Male; Single-Blind Method

1994
Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction.
    The Journal of urology, 1997, Volume: 158, Issue:4

    Topics: Alprostadil; Biological Availability; Cross-Over Studies; Erectile Dysfunction; Humans; Infusions, Intravenous; Injections; Male; Middle Aged; Vasodilator Agents

1997

Other Studies

20 other study(ies) available for 13,14-dihydroprostaglandin e1 and alprostadil

ArticleYear
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
    British journal of pharmacology, 2000, Volume: 130, Issue:8

    Topics: Binding, Competitive; Cell Line; Cell Membrane; Dinoprostone; DNA, Recombinant; Dose-Response Relationship, Drug; Humans; Ligands; Prostaglandins; Radioligand Assay; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Tritium

2000
13,14-Dihydro-prostaglandin E1 decreases low-density lipoprotein influx into rabbit aorta.
    European journal of pharmacology, 1992, Aug-14, Volume: 219, Issue:1

    Topics: Alprostadil; Animals; Aorta; Cholesterol; Endothelium, Vascular; Humans; In Vitro Techniques; Lipoproteins, LDL; Male; Rabbits

1992
Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.
    British journal of clinical pharmacology, 1992, Volume: 33, Issue:3

    Topics: Alprostadil; Ductus Arteriosus, Patent; Gas Chromatography-Mass Spectrometry; Humans; Infant, Newborn

1992
Prostaglandin (PG) E1 and 13,14-dihydro (DH) PGE1 are diminishing radiation-induced arterial damage.
    Agents and actions. Supplements, 1992, Volume: 37

    Topics: Alprostadil; Animals; Aorta, Abdominal; Arteries; Autoradiography; Dose-Response Relationship, Radiation; Extracellular Matrix; Male; Mitosis; Rabbits; Radiation Injuries, Experimental; Radiation-Protective Agents

1992
Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)--an in vivo metabolite of PGE1 in man.
    Eicosanoids, 1991, Volume: 4, Issue:3

    Topics: Alprostadil; Animals; Blood Platelets; Glucuronidase; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Rabbits; Superoxides; Vasodilation

1991
[Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Wiener klinische Wochenschrift, 1991, Volume: 103, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arterial Occlusive Diseases; Biotransformation; Dinoprostone; Female; Humans; Infusions, Intravenous; Male; Middle Aged

1991
[The pharmacology of 13,14-dihydro-PGE1 in comparison with PGE1].
    VASA. Supplementum, 1991, Volume: 33

    Topics: Alprostadil; Blood Platelets; Humans; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Function Tests; Vasoconstriction

1991
13,14-dihydro-PGE1, an in-vivo metabolite of PGE1, decreases mitotic activity induced by corticosteroid administration.
    Eicosanoids, 1991, Volume: 4, Issue:4

    Topics: Alprostadil; Animals; Aorta, Abdominal; Desoxycorticosterone; Mitosis; Rabbits; Stress, Physiological; Thymidine

1991
Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Prostaglandins, 1991, Volume: 41, Issue:3

    Topics: Alprostadil; Arterial Occlusive Diseases; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Radioimmunoassay

1991
Increase in in vivo low-density lipoprotein (LDL) receptor binding after PGE1 and 13,14-dihydro-PGE1 treatment in rabbits.
    Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:3

    Topics: Alprostadil; Animals; Cholesterol, Dietary; Hypercholesterolemia; Liver; Male; Rabbits; Receptors, LDL; Up-Regulation

1993
Gas chromatography/negative ion chemical ionization triple quadrupole mass spectrometric determination and pharmacokinetics of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostan oic acid in plasma.
    Prostaglandins, leukotrienes, and essential fatty acids, 1994, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Alprostadil; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Prostaglandins

1994
The induction of cyclooxygenase-2 elicited by endotoxin in endothelial cells and macrophages is inhibited by prostaglandin E1 and 13,14-dihydro prostaglandin E1.
    Agents and actions. Supplements, 1995, Volume: 45

    Topics: Alprostadil; Animals; Aorta; Blotting, Western; Cattle; Cells, Cultured; Endothelium, Vascular; Lipopolysaccharides; Macrophages; Mice; Prostaglandin-Endoperoxide Synthases

1995
Effects of prostaglandin E1, prostaglandin E0 and SPM 206 on isolated human coronary arteries.
    Agents and actions. Supplements, 1995, Volume: 45

    Topics: Alprostadil; Coronary Vessels; Humans; In Vitro Techniques; Muscle Contraction

1995
Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry.
    Biological mass spectrometry, 1994, Volume: 23, Issue:3

    Topics: Alprostadil; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques

1994
Effect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation.
    Thrombosis research, 1993, Aug-01, Volume: 71, Issue:3

    Topics: Alprostadil; Animals; Collagen; Drug Synergism; Humans; Male; Neutrophils; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Thrombin

1993
PGE0 inhibits collagen and glycosaminoglycan-synthesis in the rabbit arterial wall.
    VASA. Zeitschrift fur Gefasskrankheiten, 1995, Volume: 24, Issue:4

    Topics: Alprostadil; Animals; Collagen; Glycosaminoglycans; Male; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Rabbits; Vasodilator Agents

1995
Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.
    British journal of pharmacology, 1995, Volume: 116, Issue:5

    Topics: Adenosine Triphosphate; Alprostadil; Animals; Anti-Arrhythmia Agents; Biotransformation; Blood Pressure; Decanoic Acids; Electrocardiography; Glyburide; Heart Rate; Hydroxy Acids; Hypoglycemic Agents; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Rabbits; Vasodilator Agents

1995
A comparative study of the effects of iloprost and PGE1 on pulmonary arterial pressure and edema formation in the isolated perfused rat lung model.
    Prostaglandins, 1996, Volume: 51, Issue:3

    Topics: Alprostadil; Animals; Blood Pressure; Disease Models, Animal; Iloprost; In Vitro Techniques; Male; Organ Size; Perfusion; Pulmonary Artery; Pulmonary Edema; Rats; Rats, Wistar; Reproducibility of Results; Vasodilator Agents

1996
G-protein-coupled receptor agonists augment adenylyl cyclase activity induced by forskolin in human corpus cavernosum smooth muscle cells.
    Receptors & signal transduction, 1997, Volume: 7, Issue:2

    Topics: Adenylyl Cyclases; Alprostadil; Carbachol; Cells, Cultured; Colforsin; Drug Interactions; Enzyme Activation; GTP-Binding Proteins; Humans; Isoproterenol; Male; Models, Biological; Muscle Relaxation; Muscle, Smooth, Vascular; Penis; Phenylephrine; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Cholinergic; Signal Transduction

1997
Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistance.
    Prostaglandins & other lipid mediators, 1998, Volume: 55, Issue:5-6

    Topics: Alprostadil; Animals; Aorta; Arteries; Blood Platelets; Endothelium, Vascular; Humans; Iliac Artery; In Vitro Techniques; Male; Perfusion; Rabbits; Thrombosis

1998